VIPCare: virtual follow-up and monitoring using your electronic health record
Official title: VIPCare: Virtual Predictive Care workflow with EHR integrated surveillance for optimalfollow-up care management for Cancer Patients
Funded at Vizlitics INC. · NIH-11314018 · Data updated 2026-11-12
This project builds a virtual system that uses your medical record to watch for treatment effects, recurrence, and follow-up needs for people who have finished cancer treatment.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vizlitics INC. NIH-funded |
| Lab location | 1 site (Chappaqua, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $1,154,996 |
| NIH project number | 2R44CA281547-02A1 |
| Project ID | NIH-11314018 on NIH RePORTER |
Who could benefit from this research
✓Could help
People who have completed primary cancer treatment and are in post-treatment surveillance with care documented in an EHR-connected health system would be the ideal candidates.
✕Less likely to help
Patients currently in active treatment, those receiving care outside participating EHR systems, or those without consent to share EHR data may not benefit from this program.
What this research studies
You would be tracked by a digital workflow that connects to your electronic health record and looks for signs that you need tests, appointments, or further care. The system uses algorithms and EHR alerts to prioritize patients who need follow-up and to reduce manual staff work. VIPCare was previously piloted for prostate cancer during a Phase I award and now aims to expand to other cancers and broader follow-up programs. The goal is to make follow-up care more consistent, timely, and easier for both patients and clinics.
Why it matters
Potential benefit: If successful, this could help catch recurrences and treatment effects earlier and make follow-up care easier and more reliable for survivors.
How similar studies have gone: Vizlitics completed a Phase I project using VIPCare for prostate cancer showing feasibility, but wider use across cancer types is still new and being expanded.
Where this research is happening
-
Vizlitics INC.
Chappaqua, United States Active
Researchers
- Principal investigator: Bagchi, Sugato — Vizlitics INC.
- Study coordinator: Bagchi, Sugato
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.